Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

An improved long-term sales target today revitalised GSK shares after their dismal 2024. Mining stocks also rallied today after the price of gold set another record high. GSK dominated a steady FTSE ...

Banco Santander (BME: SAN) shares spiked over 6% on Wednesday after the lender unveiled plans for €10 billion (£8.3 billion) ...

As we mentioned on Tuesday, the majority of companies on the S&P 500 that have reported earnings, have beaten estimates, and ...

Strong full-year trading and an improving outlook have propelled GSK's share price higher, as Royston Wild explains. The post ...

London stocks edged higher on Wednesday as investors weighed the ongoing effects of trade tensions linked to US president ...

Stock prices in London were mixed on Wednesday afternoon, with a share price rise for GSK supporting the FTSE 100, though tariff worries continue to hang over equities. The FTSE 100 index rose 12.01 ...

Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard to make ...

Further gains propel the ounce troy of Gold to all-time highs near the $2,880 mark on the back of the weak US Dollar, ...

A recent example of content that inspired a positive response was the profiling of women in management within GSK, to mark International Women's Day which took place on 8th March. The theme of ...

Analysts predict peak sales of the drug around the $1 billion mark, but forecasts vary, partly because of the novelty of the therapy area. GSK also acquire a further meningitis candidate vaccine ...

TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying the clinical development process, will ...